Acumen Pharmaceuticals, Inc.

General ticker "ABOS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $137.4M (TTM average)

Acumen Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -4.0%.

Estimated limits based on current volatility of 5.2%: low 1.00$, high 1.10$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.11$, 3.48$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.55$, 4.28$]

Financial Metrics affecting the ABOS estimates:

  • Negative: Non-GAAP EPS, $ of -1.71 <= 0.04
  • Negative: Operating cash flow per share per price, % of -41.00 <= 1.79
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Positive: Interest expense per share, $ of 0.07 <= 0.10
  • Positive: Shareholder equity ratio, % of 76.08 > 63.75

Similar symbols

Short-term ABOS quotes

2025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-280.911.11.21.31.41.5
Price $

Long-term ABOS plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
ABOSS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $45.24MM $61.14MM $114.02MM
Operating Income $-45.24MM $-61.14MM $-114.02MM
Non-Operating Income $2.38MM $8.77MM $11.69MM
Interest Expense $0.00MM $0.58MM $4.07MM
R&D Expense $32.36MM $42.32MM $93.80MM
Income(Loss) $-42.86MM $-52.37MM $-102.33MM
Profit(Loss)* $-40.48MM $-52.37MM $-102.33MM
Stockholders Equity $188.78MM $266.97MM $181.82MM
Assets $196.59MM $310.12MM $238.99MM
Operating Cash Flow $-35.15MM $-43.06MM $-86.22MM
Capital expenditure $0.16MM $0.02MM $0.02MM
Investing Cash Flow $39.19MM $-171.67MM $48.03MM
Financing Cash Flow $3.91MM $151.75MM $6.93MM
Earnings Per Share** $-1.00 $-1.08 $-1.71

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.